Shukra Pharmaceuticals Complete Financial Statements
SHUKRAPHAR • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Shukra Pharmaceuticals (SHUKRAPHAR).
Downloads include all available records across all periods.
For market performance, see the
SHUKRAPHAR stock price today
.
Profitability Ratios
Net Profit Margin
27.03%
2025 data
EBITDA Margin
45.95%
2025 data
Operating Margin
39.00%
2025 data
Return on Assets
11.49%
2025 data
Return on Equity
15.87%
2025 data
Balance Sheet Ratios
Current Ratio
9.29
2025 data
Debt to Equity
1.38
2025 data
Equity Ratio
72.41%
2025 data
Asset Turnover
0.43
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+8.1%
Year-over-Year
Net Profit Growth
+20.0%
Year-over-Year
Expense Growth
+15.0%
Year-over-Year
Assets Growth
+11.5%
Year-over-Year
Equity Growth
+8.6%
Year-over-Year
Liabilities Growth
+11.5%
Year-over-Year
Operating Cash Flow Growth
+260.0%
Year-over-Year
Financing Cash Flow Growth
-141.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40 | 37 | 77 | 60 | 21 | 12 | 12 | 6 | 6 | 5 | 5 | 4 |
| Expenses | 23 | 20 | 55 | 54 | 18 | 10 | 10 | 4 | 4 | 4 | 4 | 3 |
| EBITDA | 17 | 17 | 22 | 7 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Operating Profit Margin % | 27.00% | 39.00% | 26.00% | 9.00% | 14.00% | 13.00% | 13.00% | 29.00% | 30.00% | 29.00% | 24.00% | -10.00% |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 13 | 20 | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Tax | 4 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 12 | 10 | 19 | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 0.90 | 0.22 | 16.93 | 26.21 | 4.79 | 1.20 | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | 0.84 |
Related Pages for Shukra Pharmaceuticals
Additional stock information and data for SHUKRAPHAR
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 | 18 |
| Current Assets | 65 | 56 | 53 | 16 | 16 | 15 | 11 | 8 | 7 | 6 | 7 |
| Fixed Assets | 19 | 20 | 20 | 18 | 18 | 17 | 16 | 14 | 10 | 10 | 10 |
| Capital Work in Progress | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 65 | 56 | 53 | 16 | 16 | 15 | 11 | 8 | 7 | 6 | 7 |
| LIABILITIES | |||||||||||
| Total Liabilities | 87 | 78 | 75 | 35 | 36 | 34 | 28 | 24 | 19 | 17 | 18 |
| Current Liabilities | 7 | 6 | 7 | 6 | 13 | 11 | 9 | 6 | 3 | 3 | 4 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 63 | 58 | 25 | 16 | 16 | 15 | 15 | 15 | 15 | 14 | 14 |
| Share Capital | 44 | 11 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves & Surplus | 19 | 47 | 21 | 15 | 14 | 14 | 14 | 13 | 13 | 13 | 12 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 8 | -5 | 3 | 8 | 1 | 1 | 0 | 1 | 0 | 3 | -2 |
| Investing Activities | -1 | -1 | -4 | -2 | -2 | -3 | -3 | -5 | -1 | 0 | 1 |
| Financing Activities | -5 | 12 | 5 | -7 | 2 | 2 | 2 | 4 | 0 | -1 | 1 |
| Net Cash Flow | 2 | 6 | 4 | 0 | 0 | 0 | 0 | -1 | -1 | 1 | 0 |